- Home
- AVD vs NVCT Comparison
AVD vs NVCT Comparison
Compare AVD & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVD | NVCT |
|---|---|---|
| Founded | 1969 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 171.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | AVD | NVCT |
|---|---|---|
| Price | $4.31 | $7.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 182.6K | 93.9K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,073,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.28 | $4.44 |
| 52 Week High | $6.33 | $11.52 |
Technical Indicators
Market Signals| Indicator | AVD | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 73.30 |
| Support Level | $4.12 | $6.47 |
| Resistance Level | $4.48 | $6.84 |
| Average True Range (ATR) | 0.19 | 0.40 |
| MACD | 0.01 | 0.17 |
| Stochastic Oscillator | 30.36 | 92.00 |
Price Performance
Historical ComparisonAbout AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.